1. Home
  2. AM vs LEGN Comparison

AM vs LEGN Comparison

Compare AM & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Antero Midstream Corporation

AM

Antero Midstream Corporation

HOLD

Current Price

$18.01

Market Cap

8.5B

Sector

Utilities

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$22.33

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AM
LEGN
Founded
2013
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
5.9B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
AM
LEGN
Price
$18.01
$22.33
Analyst Decision
Hold
Strong Buy
Analyst Count
3
13
Target Price
$18.83
$69.67
AVG Volume (30 Days)
2.3M
2.5M
Earning Date
10-29-2025
11-12-2025
Dividend Yield
5.01%
N/A
EPS Growth
20.98
N/A
EPS
0.98
N/A
Revenue
$1,249,571,000.00
$909,045,000.00
Revenue This Year
$4.60
$68.83
Revenue Next Year
$3.01
$51.27
P/E Ratio
$18.34
N/A
Revenue Growth
8.70
74.75
52 Week Low
$14.22
$22.28
52 Week High
$19.82
$45.30

Technical Indicators

Market Signals
Indicator
AM
LEGN
Relative Strength Index (RSI) 48.19 21.96
Support Level $17.91 $26.43
Resistance Level $18.88 $28.97
Average True Range (ATR) 0.37 1.57
MACD 0.02 -0.43
Stochastic Oscillator 35.79 0.91

Price Performance

Historical Comparison
AM
LEGN

About AM Antero Midstream Corporation

Antero Midstream Corp is a midstream company that owns, operates, and develops midstream energy assets that service Antero Resources' production and completion activity in the Appalachian Basin located in West Virginia and Ohio. The company has two operating segments; the Gathering and Processing segment includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio and the Water Handling segment includes two independent systems that deliver water from sources including the Ohio River, local reservoirs and several regional waterways. It derives a majority of its revenue from the Gathering and Processing segment.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: